U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. For Industry
  3. ESG Next Generation
  1. For Industry

ESG Next Generation

 

ESG NextGen Background

As part of the FY2025 PDUFA commitments, the FDA will modernize the electronic submission gateway (ESG) by implementing an improved cloud-based modernization architecture that leverages an enterprise Identity and Access Management solution and that supports greatly expanding data submission bandwidth and storage, while continuing to ensure its stable operation. The modernization of the electronic submission gateway is the Electronic Submission Gateway Next Generation (ESG NextGen).

By the end of FY 2025, FDA will complete ESG NextGen transition to the cloud, including set-up and integration of an enterprise Identity and Access Management solution that will streamline applicant access to FDA resources. Annually, FDA will share progress against the implementation project plan. FDA will engage industry to provide feedback and/or participate in pilot testing in advance of implementing significant changes that impact industry's interaction with the enterprise-wide systems.
ESG NextGen Background

ESG NextGen Vision

The FDA plans to modernize the ESG to take advantage of latest cloud technology and best-of-breed COTS software. The ESG cloud modernization, along with additional analysis and enhancements, is a part of an initiative known as the ESG NextGen solution. The vision of ESG NextGen, as illustrated in the figure below, is to provide the FDA with a trusted, secure cloud-based, and unified intake gateway that is highly available, scalable, and accepts a variety of electronic submissions for processing. The ESG NextGen will be capable of accepting all electronic submissions from industry, sponsors, manufacturers, applicants, and other governmental agencies.

ESG NextGen Vision
ESG NextGen Vision

To provide feedback, please email EsgNgSupport@fda.hhs.gov



Back to Top